oncolyt virotherapi advance since day concept therapeutic efficacy clinic seem reach level anim model one reason premature virus clearance human reason assume consider immunestimul natur agent howe sever studi begin reveal layer restrict present adapt neutral immune response barrier constitute halt infect even begin where other rail minut cue trigger index notice deli virus tumor may biggest obstacle success therapy instead physics makeup tumor caps mount antivirus defense import determine review summary constitute innate discus strategy overcome 